Disease spectrum of nonconvulsive status epilepticus in children: A study based on clinical subtype characteristics

Lianqin Mo1,2,3,4, Xiaoqi Chen1,2,3,4, Lu Yang1,2,3,4

  • 1Department of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.

Insights

Prognosis in pediatric nonconvulsive status epilepticus (NCSE) is influenced by consciousness level, EEG, and neurodevelopmental status. Identifying distinct clinical subgroups improves risk stratification and personalized treatment for better outcomes.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Pediatric status epilepticus (SE) can be complicated by nonconvulsive status epilepticus (NCSE), impacting patient prognosis.
  • Understanding risk factors and clinical heterogeneity is crucial for effective management of pediatric NCSE.

Purpose of the Study:

  • To identify risk factors for short- and long-term prognosis in pediatric NCSE.
  • To analyze clinical heterogeneity and identify prognostic subgroups within pediatric NCSE patients.

Main Methods:

  • Retrospective cohort study of 215 pediatric patients with SE and NCSE.
  • Univariate and multivariate logistic regression for outcome-associated factors.
  • Hierarchical cluster analysis for clinical phenotype subgrouping.

Main Results:

  • Independent risk factors for poor short-term prognosis included low GCS scores, developmental delay, specific EEG findings, and MRI abnormalities.
  • Poor long-term prognosis was associated with low GCS scores, developmental delay, and electroclinical syndromes.
  • Four distinct subgroups were identified: super-refractory, young-age metabolic, focal structural, and benign reactive.

Conclusions:

  • Level of consciousness, EEG, neurodevelopmental status, and electroclinical syndromes are key prognostic indicators for pediatric NCSE.
  • Clinical phenotyping and subgrouping enable individualized diagnosis, treatment, and prognostic assessment.
  • This approach addresses the need for a multidimensional stratification framework in pediatric NCSE management.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K